iCardio.ai Announces Major Additional Funding through Partnership with BSD Enterprises

Funding Will Enable iCardio.ai to Expand AI Platform and Promote Business Development

June 1, 2021 - iCardio.ai, a Los Angeles-based company that develops machine learning and deep learning algorithms for ultrasound applications, announced the closing of a strategic funding round led by BSD Enterprises that includes investments from other investors. These funds will be used to expand iCardio.ai’s AI capabilities, increase engineering headcount, and promote its flagship API service that provides intelligent echocardiographic analysis via the iCardio.AI. The partnership will also enable iCardio.ai to take advantage of existing business relationships within the BSD Enterprises network.

‍

“This strategic funding round represents a strong confidence in our platform from investors and will enable us to further improve upon our existing technology to meet growing demand, especially with the onboarding of several major customers, including GE Healthcare, this past year.” said Joseph Sokol, CEO.

‍

About BSD Enterprises

​​Operated by David Gershov, BSD Enterprises is a strategic angel investment fund focused on break-through technology startups and includes those advised by Dr. Shimon Eckhouse, a veteran Israeli medical technologist. BSD Enterprises focuses on solutions for a variety of medical applications.

For more information, please visit BSD’s website at BSD.enterprises.

‍